Juliana Soares

Dr. Juliana Soares

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
MOMiriã Cândida Oliveira
Miriã Cândida Oliveira
LALarissa R. Alves
Larissa R. Alves
JSJuliana Soares
Juliana Soares
SSShayra K. A. Souza
Shayra K. A. Souza
BSBruna M. R. Silva
Bruna M. R. Silva
LOLuis V F Oliveira
Luis V F Oliveira
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. We are increasingly recognizing complications that present after the acute phase, which are associated with impaired functional status and health-related quality of life (HRQoL). The objective was to assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. Functional status was measured with the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Medical Research Council (MRC) Dyspnea Scale, and the Post-COVID-19 Functional Status Scale (PCFS). HRQoL was confirmed with the Short-Form Health Survey 36 (SF-36). Results: We included 123 patients; 73 (59.35%) were male, with a mean age of 49.17 ± 13.48 years and a body mass index of 31.02 ± 6.56 stratified into three groups: the not-recovered group (NRG = 23), the ward-recovered group (WHG = 60), and the intensive-care-unit group (ICUG = 40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). The predicted distances for the 6MWT were missed by 12.83% by the GNR group, 20.21% by the GNR group, and 28.82% by the UGCI group. The MRC dyspnea scale had a mean value of less than 3, and the FSS scale had a mean value of over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p < 0.0005), while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.

31 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MOMiriã Cândida Oliveira
Miriã Cândida Oliveira
LALarissa Alves
Larissa Alves
JSJuliana Soares
Juliana Soares
SSShayra Souza
Shayra Souza
AFAdriano Fonseca
Adriano Fonseca
BSBruna Silva
Bruna Silva
Background: COVID-19 mainly affects the respiratory system, although its manifestations are multisystemic. Increasingly, complications presented after the acute phase are still being rec-ognized and are associated with impaired functional status and health-related quality of life (HRQoL). The objective was assess the functional status and HRQoL of patients with post-COVID-19. Methods: This was a cross-sectional study involving individuals affected by COVID-19 who had persistent symptoms for one month after the acute phase of the disease. HRQoL was verified through the Short Form Health Survey 36 (SF-36) and, functional status was assessed using the six-minute walk test (6MWT), the Fatigue Severity Scale (FSS), the Med-ical Research Council (MRC) Dyspnea Scale and, the Post-COVID-19 Functional Status Scale (PCFS). Results: Were included 123 patients, 73 (59.35%) were male, with a mean age of 49.17±13.48 years and a body mass index of 31.02±6.56 stratified into three groups, not recov-ered group (NRG=23), ward recovered group (WHG=60), and intensive care unit group (ICUG=40). The main symptoms were muscle weakness (74.17%) and dyspnea (68.33%). In rela-tion to the distance covered in the 6MWT, the GNR group walked 12.83% below the predicted values, GNR 20.21% and the UGCI 28.82%, respectively. The MRC dyspnea scale had a mean value of less than 3 and the FSS scale had a mean value over 4, indicating considerable fatigue. In the PCFS scale, a significant difference was observed (p>0.0005); while in the SF-36, all HRQoL domains were compromised. Conclusion: Post-COVID-19 patients involved in this study showed a significant decline in functional status and an impairment of HRQoL.

1 November 2024 in Cuadernos de Educación y Desarrollo
Verified
Journal Article
Open access
PDF file
JJJairo Belém Soares Ribeiro Júnior
Jairo Belém Soares Ribeiro Júnior
LALarissa Rodrigues Alves
Larissa Rodrigues Alves
MOMiriã Cândida Oliveira
Miriã Cândida Oliveira
PGPatricia Regina Alves Galdeano
Patricia Regina Alves Galdeano
GSGuilherme Quireza Silva
Guilherme Quireza Silva
LOLuis V F Oliveira
Luis V F Oliveira
Introduction: Schizophrenia affects about 1% of the population, starting before the age of 25 and persisting throughout life. The disease is characterized by the presence of positive symptoms such as delusions, hallucinations, thought disorganization, negative symptoms such as affective flattening, withdrawal, isolation, as well as cognitive symptoms, such as changes in attention and memory. Objective: To report a case of severe schizophrenia that presented a high degree of functional impairment and life cycle disruption. Methods: These informations was obtained through the collection of clinical data from the patient's medical record, information from family members and, the clinical evaluation. Results: The patient's mother reported the onset of symptoms at the age of 16, when her son would get very irritable for any reason. After killing his stepfather, the patient was caught in the act and taken to the Juvenile Detention Center. The patient tried to hang himself with his own hands several times, and was then admitted to a psychiatric clinic. He was treated with clozapine, starting with 25 mg and reaching a dose of 700 mg per day, without side effects of neutropenia, seizures, and sialorrhea. During his evolution, while still hospitalized, he showed good progress, with a reduction in delusions and hallucinations, demonstrating insight into his illness and self-criticism, returning to functionality. After being discharged from the hospital, he returned to social life with the family. Discussion: Schizophrenia can evolve severely, leading to the breakdown of the patient's life cycle, serious dysfunctions, and irreversible damage in biological, psychological, and social aspects. Poor adherence to treatment, the side effects of medications, refractoriness to drugs and therapies, as well as the use of illicit drugs, can be elements that, individually or in combination, worsen the prognosis of the disease. The use of clozapine is an important resource that can be used in cases refractory to other medications, bringing results. Conclusion: Even in the face of the patient's severe condition, there was a good response to treatment with clozapine.